New Additions to the BG Leadership Team

Baylor Genetics is proud to announce new additions to our Leadership team. Please give a warm welcome to Tim Webster, VP of Clinical Operations and Lori Aro, VP of Product. We look forward to their contributions to BG and the positive impact it will have on our clients and their patients.


Tim Webster, VP of Clinical Operations:
Tim is a talented executive laboratory professional with a strong background in molecular and anatomic pathology operations, process improvement, accreditation, regulatory/compliance, and project management. Tim has worked in both the academic healthcare and private industry settings at Northwestern Medicine, Strata, and Seacoast Pathology. Tim has a MA in organizational management from Ashford University and a degree from the Royal Army Medical College, London.


Lori Aro, VP of Product:
Lori joins Baylor Genetics from Pacific Biosciences with executive leadership experience in product development and life cycle management in the highly competitive molecular diagnostic market. She is well versed in balancing clinical and commercial unmet needs with scientific feasibility to conceptualize new product candidates across multiple channels and therapeutic areas to accelerate growth. Lori has a bachelor’s in public health and an MBA, both from the University of Utah.

Previous Post
Test Launch // Whole Exome Sequencing & Whole Genome Sequencing (Proband, Duo, Rapid Options)
Next Post
Susan Campbell joins Baylor Genetics Executive Team as Senior VP of Commercial Operations